Close

UBS Positive on Cardinal Health's (CAH) CVS Joint Venture; Boosts PT to $75

December 11, 2013 11:41 AM EST Send to a Friend
Analysts at UBS had positive commentary on Cardinal Health (NYSE: CAH) Wednesday amid the analyst meeting which came with an ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login